The Revolutionary Impact of AxioMed's Viscoelastic Discs in Spine Surgery
In a significant development for spinal surgery, a study published in The Journal of Bone and Joint Surgery (JBJS) has provided robust peer-reviewed evidence supporting AxioMed's innovative viscoelastic lumbar disc replacement. This research sheds light on why this advanced technology outperforms traditional ball-and-socket designs in terms of both durability and biocompatibility, making it a pivotal option for patients seeking long-term solutions in spinal care.
For the past two decades, advancements in spinal arthroplasty have faced serious setbacks due to the withdrawal of several high-profile ball-and-socket discs, such as CHARITÉ® and prodisc® M6®. The underlying issue often stemmed from excessive wear that triggered a biological response, leading to bone deterioration – known as osteolysis, a complication triggered by wear debris generated from traditional joint designs.
The newly published JBJS study, titled "Comparative in Vitro Analysis of Wear Particles Generated by a Viscoelastic Disc Versus 2 Articulating Total Disc Replacements," highlights that AxioMed's viscoelastic lumbar disc replacement produces significantly fewer and biologically more favorable wear particles than articulating alternatives. This finding marks a substantial shift in the quest for effective motion-preserving technologies in spine surgery.
This pivotal study discovered the mechanical and biological discrepancies between AxioMed's viscoelastic disc and conventional articulating designs, revealing the mechanics at play in relation to wear output:
Professor Kingsley R. Chin, MD, MBA, the study’s lead author and CEO of KIC Ventures, commented, "Our goal was never truly to develop a 'better joint,' but to recreate the natural function of a disc. This publication validates that our viscoelastic solution can significantly curtail wear while generating less reactive particles—an explanation for our technology's robust clinical track record over the past decade compared to articulating disc designs."
Echoing this sentiment, Dr. Erik Spayde, MD, Chief Medical Officer at AxioMed, underscored the innovative aspect of their product: "Having worked across various disc technologies for over 20 years, I recognized the limitations of conventional designs. AxioMed operates fundamentally differently; it absorbs load and distributes forces like a natural disc. We are paving the way for the future of motion preservation."
The timing of this research arrives at an opportune moment as the spine care market is seeing changes in payer coverage, with major U.S. insurance plans now adequately covering lumbar disc replacement. The success of high-profile athletes, particularly Tiger Woods, pivoting towards preservation strategies has fueled patient demand for alternatives to traditional spinal fusion methodologies. AxioMed is proud to boast a clinical follow-up of over 10 years, maintaining nearly 1,000 implants worldwide without any reported device failures.
In conclusion, the JBJS study epitomizes a critical advancement in spinal surgery technology, confirming that AxioMed's viscoelastic design yields a durable, biocompatible solution conducive to long-term motion preservation, marking a notable achievement in the evolution of spine surgery. Read the comprehensive study on PubMed for deeper insights into this groundbreaking technology.
Addressing the "Wear Crisis"
For the past two decades, advancements in spinal arthroplasty have faced serious setbacks due to the withdrawal of several high-profile ball-and-socket discs, such as CHARITÉ® and prodisc® M6®. The underlying issue often stemmed from excessive wear that triggered a biological response, leading to bone deterioration – known as osteolysis, a complication triggered by wear debris generated from traditional joint designs.
The newly published JBJS study, titled "Comparative in Vitro Analysis of Wear Particles Generated by a Viscoelastic Disc Versus 2 Articulating Total Disc Replacements," highlights that AxioMed's viscoelastic lumbar disc replacement produces significantly fewer and biologically more favorable wear particles than articulating alternatives. This finding marks a substantial shift in the quest for effective motion-preserving technologies in spine surgery.
Key Findings from the Study
This pivotal study discovered the mechanical and biological discrepancies between AxioMed's viscoelastic disc and conventional articulating designs, revealing the mechanics at play in relation to wear output:
- - Enhanced Particle Size: The AxioMed disc generates larger particles (averaging 1.9 μm), which are less likely to provoke the aggressive inflammatory reactions that often lead to implant loosening and deteriorating bone structure seen in ball-and-socket models, characterized by the generation of smaller particles (0.2 μm to 0.4 μm).
- - Lower Wear Rates: The AxioMed design showcased a remarkable 70% reduction in wear rate, averaging 1.7 mg/MC compared to the 5.7 mg/MC of the prodisc L.
- - Structural Integrity: The study confirms that the viscoelastic core deftly maintains its performance despite varied movement challenges such as lateral bending and axial rotation.
- - Biocompatibility: By mimicking native disc physiology rather than mechanical joints, the viscoelastic design minimizes the body’s rejection risk, making it biologically safer and more harmonious with the human anatomy.
Insights from Leading Experts
Professor Kingsley R. Chin, MD, MBA, the study’s lead author and CEO of KIC Ventures, commented, "Our goal was never truly to develop a 'better joint,' but to recreate the natural function of a disc. This publication validates that our viscoelastic solution can significantly curtail wear while generating less reactive particles—an explanation for our technology's robust clinical track record over the past decade compared to articulating disc designs."
Echoing this sentiment, Dr. Erik Spayde, MD, Chief Medical Officer at AxioMed, underscored the innovative aspect of their product: "Having worked across various disc technologies for over 20 years, I recognized the limitations of conventional designs. AxioMed operates fundamentally differently; it absorbs load and distributes forces like a natural disc. We are paving the way for the future of motion preservation."
A Shift in Spine Care Landscape
The timing of this research arrives at an opportune moment as the spine care market is seeing changes in payer coverage, with major U.S. insurance plans now adequately covering lumbar disc replacement. The success of high-profile athletes, particularly Tiger Woods, pivoting towards preservation strategies has fueled patient demand for alternatives to traditional spinal fusion methodologies. AxioMed is proud to boast a clinical follow-up of over 10 years, maintaining nearly 1,000 implants worldwide without any reported device failures.
In conclusion, the JBJS study epitomizes a critical advancement in spinal surgery technology, confirming that AxioMed's viscoelastic design yields a durable, biocompatible solution conducive to long-term motion preservation, marking a notable achievement in the evolution of spine surgery. Read the comprehensive study on PubMed for deeper insights into this groundbreaking technology.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.